Publications
View AllEffects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
Ramipril significantly reduces the rates of death, myocardial infarction, and stroke in a broad range of high-risk patients who are not known to have a low ejection fraction or ...
Affiliated Researchers
Institution Info
- Type
- healthcare
- Country
- CA
- Publications
- 2
- Citations
- 20,277
External Links
Identifiers
- ROR
- https://ror.org/05q8mwj81